RBC Capital Downgrades Medtronic to Sector Perform, Lowers Price Target to $89
RBC Capital analyst Shagun Singh downgrades Medtronic (NYSE:MDT) from Outperform to Sector Perform and lowers the price target from $102 to $89.
Looking Into Medtronic’s Recent Short Interest
Medtronic's (NYSE:MDT) short percent of float has fallen 4.17% since its last report. The company recently reported that it has 9.15 million shares sold short, which is 0.69% of all regular shares that are available for trading.
Medtronic Announces First Patient Enrolled In U.S. Clinical Trial For Hugo Robotic-assisted Surgery System
Medtronic plc (NYSE:MDT), a global healthcare technology leader, today announced the first patient enrolled in the Expand URO U.S. clinical trial for the Hugo™ robotic-assisted surgery (RAS) system. The
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Universal Health Services To Rally Around 25%? Here Are 5 Other Price Target Changes For Friday
Credit Suisse raised Universal Health Services, Inc. (NYSE: UHS) price target from $129 to $157. Credit Suisse analyst Jonathan Yong maintained an Outperform rating on the stock. Universal Health fell 2.7% to $126.15 in pre-market trading.
Barclays Maintains Equal-Weight on Medtronic, Lowers Price Target to $85
Barclays analyst Matt Miksic maintains Medtronic (NYSE:MDT) with a Equal-Weight and lowers the price target from $90 to $85.
What 10 Analyst Ratings Have To Say About Medtronic
Within the last quarter, Medtronic (NYSE:MDT) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish…
10 Analysts Have This to Say About Medtronic
Medtronic (NYSE:MDT) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish…